Rhumbline Advisers Has $179,000 Stock Position in Design Therapeutics, Inc. (NASDAQ:DSGN)
Rhumbline Advisers trimmed its stake in shares of Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) by 12.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,369 shares of the company’s stock after selling 6,563 shares during the quarter. Rhumbline Advisers’ holdings in Design […]
Rhumbline Advisers trimmed its stake in shares of Design Therapeutics, Inc. (NASDAQ:DSGN – Free Report) by 12.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 46,369 shares of the company’s stock after selling 6,563 shares during the quarter. Rhumbline Advisers’ holdings in Design […]
